Doxazosin suppresses the morning increase in blood pressure and sympathetic nervous activity in patients with essential hypertension

Hypertension Research

Volumn 20, Issue 3, 1997, Pages 149-156

  Kawano, Yoshiyuki ^a   Tochikubo, Osamu ^c   Watanabe, Yasujiro ^a   Miyajima, Eiji ^c   Ishii, Masao ^b  

^a Nanasawa Rehabilitation Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Doxazosin; Essential hypertension; Morning increase in blood pressure; Sympathetic nervous activity

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; DOXAZOSIN MESYLATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY POSTURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HUMAN; MALE; PHYSICAL ACTIVITY; POWER SPECTRUM; RR INTERVAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE;

EID: 0030717702     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.20.149     Document Type: Article

References (27)

1. Muller JE, Ludmer PL, Willich SN, et al. Circadian Variation in the frequency of sudden cardiac death. Circulation 1987; 75: 131-138.
2. Muller JE, Stone PH, Turi ZG, et al: Circadian variation in the frequency of onset of acute myocar-dial infarction. N Engl J Med 1985; 313: 1315-1322.
3. Agnoli A, Manfredi M, Mossuto L, Piccinelli A: Relationship between circadian rhythm and blood pressure and the pathogenesis of cerebrovascular insuf-ficiency (in French). Rev Neurol 1975; 131: 597-606.
4. Lucente M, Rebuzzi AG, Lanza GA, et al: Circadian variation of ventricular tachycardia in acute myocardial infarction. Am J Cordial 1988; 62: 670-674.
5. Quyyumi AA, Panza JA, Diodati JG, Lakatos E, Epstein SE: Circadian variation in ischemic threshold: a mechanism underlying the circadian variation in ischemic events. Circulation 1992; 86: 22-28.
6. van Boven AJ, Brouwer J, Crijns HJGM, Haaksma J, Lie KI: Differential autonomic mechanisms underlying early morning and daytime transient myocardial ischaemia in patients with stable coronary artery disease. Br Heart J 1995; 73: 134-138
7. Tochikubo O, Ikeda A, Miyajima E, Ishii M: Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318-1324.
8. American National Standard: Electronic or automated sphygmonanometers. Arlington, Association for the Advancement of Medical Instrumentation, 1993, pp 1-39.
9. Malliani A, Pagani M, Lombardi F, Cerutti S: Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492.
10. Rocco MB, Barry JJ, Campbell S, et al: Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987; 75: 395-400.
11. Kuwajima I, Mitani K, Miyao M, Suzuki Y, Kuramoto K, Ozawa T: Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time. Am J Hypertens 1995; 8: 29-33.
12. Millar-Craig MW, Bishop CN, Raftery EB: Circadian variation of blood-pressure. Lancet 1978; 1: 795-797.
13. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-254.
14. Davies MJ, Thomas AC: Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985; 53: 363-373.
15. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S: Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: role of exercise-induced coronary arterial spasm. Circulation 1979; 59: 938-948.
16. Tsukiyama H, Otsuka K, Horii M, Takasaki I: Hemodynamic effects of tilisolol, a new′β-adrenergic blocking agent with vasodilating property, and doxazosin, a new α-adrenergic blocking agent, in essential hypertension. Jpn J-Clin Pharmacol Ther 1988; 19: 511-517.
17. Tsunoda K, Abe K: α-adrenergic receptor blockade. Nihon-Rinsyo 1992; 50: 703-714.
18. Kawano Y, Tochikubo O, Minamisawa K, Miyajima E, Ishii M: Circadian variation of haemodynamics in patients with essential hypertension: comparison between early morning and evening. J Hypertens 1994; 12: 1405-1412.
19. Parati G, Saul JP, Di Rienzo M, Mancia G: Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension 1995; 25: 1276-1286
20. Yasue H, Touyama M, Kato H, Tanaka S, Akiyama F: Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography. Am Heart J 1976; 91: 148-155.
21. Gagnon DR, Zhang TJ, Brand FN, Kannel WB: Hematocrit and the risk of cardiovascular disease: the Framingham study: a 34-year follow-up. Am Heart J 1994; 127: 674-682.
22. Tofler GH, Brezinski D, Schafer AI, et al: Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514-1518.
23. 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Ther Res 1994; 15: 461-468.
24. Hayashi H, Ohno M, Ogawa S, et al: The effect of doxazosin on circadian rhythm of blood pressure in patients with essential hypertension. Ther Res 1991; 12: 529-537.
25. 1-blocker (doxazosin) on diurnal blood pressure variation in dipper and non-dipper type hypertension. Hypertens Res 1995; 18: 125-130.
26. Kuwajima I, Toyoshima T, Nakamura M, Yamashina A, Takao N: Effects of doxazosin mesilate on the morning increase of blood pressure (in Japanese). Ketsuatu 1996; 3: 388-393.
27. Pickering TG, Levenstein M, Walmsley P, the Hypertension and Lipid Trial Study Group: Night time dosing of doxazosin has peak effect on morning ambulatory blood pressure: results of the HALT study. Am J Hypertens 1994; 7: 844-847.